Lyn-IN-1

CAS No. 887650-05-7

Lyn-IN-1( —— )

Catalog No. M16418 CAS No. 887650-05-7

Lyn-IN-1 is a potent and selective dual Bcr-Abl/Lyn inhibitor.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
2MG 59 Get Quote
5MG 88 Get Quote
10MG 159 Get Quote
25MG 296 Get Quote
50MG 501 Get Quote
100MG 618 Get Quote
200MG 860 Get Quote
500MG Get Quote Get Quote
1G Get Quote Get Quote

Biological Information

  • Product Name
    Lyn-IN-1
  • Note
    Research use only, not for human use.
  • Brief Description
    Lyn-IN-1 is a potent and selective dual Bcr-Abl/Lyn inhibitor.
  • Description
    Lyn-IN-1 is a potent and selective dual Bcr-Abl/Lyn inhibitor.
  • In Vitro
    ——
  • In Vivo
    ——
  • Synonyms
    ——
  • Pathway
    Angiogenesis
  • Target
    Bcr-Abl
  • Recptor
    Bcr-Abl
  • Research Area
    Cancer
  • Indication
    ——

Chemical Information

  • CAS Number
    887650-05-7
  • Formula Weight
    576.6154
  • Molecular Formula
    C30H31F3N8O
  • Purity
    >98% (HPLC)
  • Solubility
    10 mM in DMSO
  • SMILES
    CC1=C(C=C(C=C1)NC(=O)C2=CC(=C(C=C2)CN3CCC(C3)N(C)C)C(F)(F)F)NC4=NC=C(C=N4)C5=CN=CN=C5
  • Chemical Name
    Benzamide, N-[3-([5,5'-bipyrimidin]-2-ylamino)-4-methylphenyl]-4-[[(3S)-3-(dimethylamino)-1-pyrrolidinyl]methyl]-3-(trifluoromethyl)-

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1. From PCT Int.Appl.(2014), WO2014169128A1
molnova catalog
related products
  • Nilotinib monohydroc...

    A potent, selective, orally available inhibitor of both native and mutant Bcr-Abl with IC50 of 20-80 nM.

  • PPY A

    PPY A is a potent inhibitor of T315l mutant and wild-type Abl kinase (IC50 of 9 and 20 nM, respectively).PPY A also inhibits the growth of Bcr-Abl T315l mutant or wild-type Bcr-Abl genetically transformed cells.

  • AN-019

    AN-019 (NRC-019) is a Bcr-Abl kinase inhibitor with antitumor activity for the study of chronic myelogenous leukemia (CML) and breast cancer.